Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | RAF1 | P04049 | 15/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 8/20 | 0.51 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161668 | 0.81 | RAF1 (0.56) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL1912421 | 0.79 | RAF1 (0.51) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL173108 | 0.79 | RAF1 (0.56) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL9965178 | 0.79 | RAF1 (0.51) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL161941 | 0.79 | L3MBTL1 (0.60) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL14467713 | 0.78 | RAF1 (0.60) | RAF1MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL27928358 | 0.76 | L3MBTL1 (0.57) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL13425471 | 0.76 | RAF1 (0.65) | RAF1MAPK14MAPK13MAPK12MAPK11 | |
| SCHEMBL3219082 | 0.76 | RAF1 (0.48) | L3MBTL1RAF1MAPK14MAPK13MAPK12 | |
| SCHEMBL10308320 | 0.76 | RAF1 (0.69) | RAF1MAPK14MAPK13MAPK12MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012006055-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-01-12 | — | — | WO | disclosed |